Please assess the completion status of the following clinical trial:

Trial Title: Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age : 0-2 years old~2. Weight : less than the 95th percentile for age and height ( no more than 15kg )~3. ASA classification : I-II~4. Meets the hospital and department of anesthesiology guidelines with respect to peri-operative care~Exclusion Criteria:~1. History of heart disease~2. Any condition predisposing to arrhythmia~3. Any medication known to influence the heart rate~4. Child taking anti-cholinergic medication routinely~5. The use of succinylcholine anticipated (will cause bradycardia)~6. Rapid sequence intubation is required (due to aspiration risk)~7. Known difficult airway (may be difficult to bag mask ventilate)

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 2 Years
- Healthy Volunteers: f

Study Arms:
- Infants and children less than 15Kg. (Type: EXPERIMENTAL): This group consists of children who are ASA physical status I and II, less than 2 years of age and scheduled for elective surgical procedure and weigh less than 15Kg will receive atropine 5 mcg/kg IV during sevoflurane anesthesia.

Based on this trial design, predict the completion outcome and termination type (if applicable).